Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) EBIAT (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed EBIAT for 16 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • Quarterly EBIAT rose 126.04% to $1.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Sep 2025, up 109.96% year-over-year, with the annual reading at -$16.4 million for FY2024, 2592.27% down from the prior year.
  • EBIAT for Q3 2025 was $1.3 million at Xtant Medical Holdings, down from $3.6 million in the prior quarter.
  • The five-year high for EBIAT was $9.2 million in Q3 2023, with the low at -$5.0 million in Q3 2024.
  • Average EBIAT over 5 years is -$1.3 million, with a median of -$2.2 million recorded in 2023.
  • The sharpest move saw EBIAT plummeted 7531.03% in 2022, then skyrocketed 492.31% in 2023.
  • Over 5 years, EBIAT stood at -$2.3 million in 2021, then increased by 3.24% to -$2.2 million in 2022, then plummeted by 94.79% to -$4.3 million in 2023, then rose by 26.45% to -$3.2 million in 2024, then surged by 141.33% to $1.3 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at $1.3 million, $3.6 million, and $58000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.